Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Robin Ohls, MD
University of Utah
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Stanford University
Palo Alto, California, United States
- Emory University
Atlanta, Georgia, United States
- University of Iowa
Iowa City, Iowa, United States
- University of New Mexico
Albuquerque, New Mexico, United States
- University of Rochester
Rochester, New York, United States
- Duke University
Durham, North Carolina, United States
- Rti International
Durham, North Carolina, United States
- Cincinnati Children'S Medical Center
Cincinnati, Ohio, United States
- Case Western Reserve University, Rainbow Babies and Children'S Hospital
Cleveland, Ohio, United States
- Research Institute at Nationwide Children'S Hospital
Columbus, Ohio, United States
- Univeristy of Pennsylvania
Philadelphia, Pennsylvania, United States
- Brown University - Women and Infants Hospital of Rhode Island
Providence, Rhode Island, United States
- University of Texas Southwestern Medical Center at Dallas
Dallas, Texas, United States
- University of Texas Health Science Center at Houston
Houston, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Sept 2017
- Primary completion
- 23 Dec 2022
- Completion
- 12 May 2025
- Last update posted
- 1 Jul 2026
- Registered enrollment
- 650
- Registry id
- NCT03169881
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.